CN101951964B - 成像方法 - Google Patents

成像方法 Download PDF

Info

Publication number
CN101951964B
CN101951964B CN200880117542.XA CN200880117542A CN101951964B CN 101951964 B CN101951964 B CN 101951964B CN 200880117542 A CN200880117542 A CN 200880117542A CN 101951964 B CN101951964 B CN 101951964B
Authority
CN
China
Prior art keywords
chemical compound
formula
purposes
group
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880117542.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101951964A (zh
Inventor
S·彻蒂比
B·牛顿
M·索尔贝肯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of CN101951964A publication Critical patent/CN101951964A/zh
Application granted granted Critical
Publication of CN101951964B publication Critical patent/CN101951964B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CN200880117542.XA 2007-11-19 2008-11-19 成像方法 Expired - Fee Related CN101951964B (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US98884007P 2007-11-19 2007-11-19
US60/988,840 2007-11-19
GBGB0722650.9A GB0722650D0 (en) 2007-11-19 2007-11-19 Novel imaging method
GB0722650.9 2007-11-19
US60/988840 2007-11-19
PCT/EP2008/065824 WO2009071444A2 (en) 2007-11-19 2008-11-19 Novel imaging method

Publications (2)

Publication Number Publication Date
CN101951964A CN101951964A (zh) 2011-01-19
CN101951964B true CN101951964B (zh) 2013-05-29

Family

ID=38896533

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880117542.XA Expired - Fee Related CN101951964B (zh) 2007-11-19 2008-11-19 成像方法

Country Status (8)

Country Link
US (1) US8834843B2 (https=)
EP (1) EP2219681A2 (https=)
JP (1) JP5709522B2 (https=)
CN (1) CN101951964B (https=)
BR (1) BRPI0820430A2 (https=)
GB (1) GB0722650D0 (https=)
RU (1) RU2505316C2 (https=)
WO (1) WO2009071444A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2571486C1 (ru) * 2014-11-05 2015-12-20 Общество с ограниченной ответственностью "ДИАМЕД" Способ визуализации воспалений
EP3967704A4 (en) * 2019-06-11 2022-08-31 FUJIFILM Corporation CYCLIC PEPTIDE, CELL SCAFFOLD MATERIAL, CELL SEPARATOR MATERIAL AND CULTURE MEDIUM

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054904A2 (en) * 2004-11-22 2006-05-26 Ge Healthcare As Contrast agents to target extracellular matrix
WO2007066115A2 (en) * 2005-12-08 2007-06-14 Ge Healthcare Limited Novel imaging agents for fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0210886B8 (pt) * 2001-07-10 2021-05-25 Amersham Health As composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
US20040223912A1 (en) * 2003-05-07 2004-11-11 Montalto Michael Christopher Compositions and methods for non-invasive imaging of soluble beta-amyloid
GB0317815D0 (en) 2003-07-30 2003-09-03 Amersham Health As Imaging agents
ATE399542T1 (de) * 2003-10-01 2008-07-15 Merck Patent Gmbh Alfavbeta3 und alfavbeta6 integrin antagonisten als antifibrotische mittel
EP1833512A1 (en) 2005-01-06 2007-09-19 GE Healthcare AS Optical imaging
WO2006115416A2 (en) 2005-04-25 2006-11-02 Ge Healthcare As Liposomes
CA2663749A1 (en) * 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
WO2007148074A1 (en) 2006-06-21 2007-12-27 Hammersmith Imanet Limited Chemical methods and apparatus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054904A2 (en) * 2004-11-22 2006-05-26 Ge Healthcare As Contrast agents to target extracellular matrix
WO2007066115A2 (en) * 2005-12-08 2007-06-14 Ge Healthcare Limited Novel imaging agents for fibrosis

Also Published As

Publication number Publication date
GB0722650D0 (en) 2007-12-27
CN101951964A (zh) 2011-01-19
JP2011506273A (ja) 2011-03-03
WO2009071444A9 (en) 2009-10-01
WO2009071444A2 (en) 2009-06-11
US20100316565A1 (en) 2010-12-16
EP2219681A2 (en) 2010-08-25
US8834843B2 (en) 2014-09-16
WO2009071444A3 (en) 2009-12-23
BRPI0820430A2 (pt) 2015-05-26
RU2010119187A (ru) 2011-12-27
RU2505316C2 (ru) 2014-01-27
JP5709522B2 (ja) 2015-04-30

Similar Documents

Publication Publication Date Title
CN101454026B (zh) 成像剂
EP0772628B1 (en) Peptide derived radionuclide chelators
ES2844586T3 (es) Inhibidores del antígeno prostático específico de membrana (PSMA) etiquetados con 18F y su uso como agentes de obtención de imágenes para el cáncer de próstata
US9550001B2 (en) Compositions, methods of synthesis and use of carbohydrate targeted agents
EP0746340B1 (en) Peptide-chelator conjugates
EP0733060B1 (en) Metal chelators
CN114773433B (zh) 一种cd25靶向多肽、分子探针及应用
CN101325978A (zh) 用于纤维化的新显像剂
US20210347890A1 (en) Cd31shed as a molecular target for imaging of inflammation
Yim et al. Synthesis and preclinical characterization of [64Cu] NODAGA-MAL-exendin-4 with a Nε-maleoyl-l-lysyl-glycine linkage
CN112043839A (zh) 靶向转铁蛋白受体的放射性同位素标记多肽显像剂及其应用
Nock et al. Novel bifunctional DATA chelator for quick access to site-directed PET 68 Ga-radiotracers: preclinical proof-of-principle with [Tyr 3] octreotide
CN101951964B (zh) 成像方法
US7122622B2 (en) Peptide compounds having improved binding affinity to somatostatin receptors
TWI671077B (zh) 六聚乳糖NOTA衍生物、六聚乳糖正子肝受體造影劑的Ga-68放射標誌方法及六聚乳糖正子肝受體造影劑
JP7091241B2 (ja) 固形ガンのための新規なキニンベースのセラノスティックプローブとその使用
JP2008509921A (ja) 内皮特異的な生体内伝達のターゲティング剤としての熱ショックタンパク質
EP4640240A1 (en) Peptide-based radiopharmaceuticals for non-invasive imaging of the functional liver reserve
CN119613501A (zh) 靶向肿瘤整合素α5β1的PET示踪剂及其标记前体、制备方法和应用
CN115996761A (zh) 用于诊断和/或监测纤维化的化合物
KR20120027023A (ko) 섬유생성화의 ｐｅｔ 영상화
Hua Research Progress on Asialoglycoprotein Receptor-Targeted Radiopharmaceuticals Designed for Hepatic Nuclear Medicine Imaging

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130529

Termination date: 20161119

CF01 Termination of patent right due to non-payment of annual fee